Aug 28, 2007 by Andrew R. VainoCardiome's Hearty OutlookIf the FDA renders a favorable decision on an anti-fibrillation drug, Cardiome's heart may well skip a beat.
Aug 13, 2007 by Andrew R. VainoDo You See What I WuXi?This Chinese biotech outsourcing firm recently went public and has lots of room to grow.
Aug 6, 2007 by Andrew R. VainoNPS Pharmaceuticals: What's for Dinner?The small biotech pins its hopes on a drug that helps patients digest their food.
Aug 2, 2007 by Andrew R. VainoAriad Gets OverlookedA significant deal with Merck doesn't impress the Street.
Jul 20, 2007 by Andrew R. VainoBioCryst Is for the BirdsFears of bird flu resurrected a drug for this small pharma, and it has some other promising compounds in the pipeline.
Jul 17, 2007 by Andrew R. VainoProblems Posed for PozenIf its latest drug isn't approved, the pharmaceutical could face trouble.
